VolitionRX Limited Common Stock
VNRX US9286611077
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-17% | -25% | -70% | -43% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Innes Guy Archibald |
0.54 USD |
20,000 Bought |
10,772 USD |
01/01/1970 | 01/01/1970 |
Innes Guy Archibald |
0.77 USD |
20,000 Bought |
15,400 USD |
01/01/1970 | 01/01/1970 |
Innes Guy Archibald |
0.67 USD |
150,000 Bought |
100,500 USD |
01/01/1970 | 01/01/1970 |
Innes Guy Archibald |
0.54 USD |
20,000 Bought |
10,772 USD |
01/01/1970 | 01/01/1970 |
Innes Guy Archibald |
0.71 USD |
20,000 Bought |
14,200 USD |
01/01/1970 | 01/01/1970 |
Reynolds Cameron John CEO |
0.67 USD |
10,000 Bought |
6,700 USD |
01/01/1970 | 01/01/1970 |
Innes Guy Archibald |
0.55 USD |
181,818 Bought |
100,000 USD |
01/01/1970 | 01/01/1970 |
Micallef Jacob Vincent CSO |
0.57 USD |
43,691 Bought |
25,000 USD |
01/01/1970 | 01/01/1970 |
Innes Guy Archibald |
0.76 USD |
10,000 Bought |
7,600 USD |
01/01/1970 | 01/01/1970 |
Butera Salvatore Thomas CEO |
0.83 USD |
10,000 Bought |
8,300 USD |
01/01/1970 | 01/01/1970 |